Muscle invasive bladder cancer: A single sample patient assay to predict molecular subtypes and benefit of neoadjuvant chemotherapy
Roland Seiler(University of British Columbia), P. Black, Elai Davicioni(Coherus BioSciences (United States)), Matthew Sommerlad, Beatrix Palmer-Aronsten(Genome British Columbia), Ewan A. Gibb(BC Cancer Agency), Lucia L.C. Lam(Genome British Columbia), T. Todenhöfer(University of British Columbia), W. Kim, S. North, Ellen C. Zwarthoff(Erasmus MC), Jordan Kardos(University of North Carolina at Chapel Hill), Won‐Jun Choi, Seth P. Lerner(Baylor College of Medicine), N. Erho, Kim van Kessel(Erasmus MC Cancer Institute), David J. McConkey(Johns Hopkins University), E. Fransen Van De Putte, Q. Wang, G. Thalmann, Gottfrid Sjödahl(Lund University), Bernhard Kiss(University of Bern), Simon J. Crabb(University of Southampton), Joost L. Boormans(Erasmus MC), Jonathan L. Wright(Seattle University), Marc Dall’Era(University of California, Davis), Voleak Choeurng, James Joshua Douglas, H.A.D.M. Ashab(Genome British Columbia), Brian Winters(University of Washington), M. van der Heijden(The Netherlands Cancer Institute), Katherine A. Hoadley(University of North Carolina at Chapel Hill), Bas W. van Rhijn(University of Regensburg), Christine Buerki(Genome British Columbia)
Cited by 1
Related Papers
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
|Cell|2018|4k
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
|Cell|2018|2.8k
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
|Cancer Cell|2017|2.1k